Search Results

You are looking at 1 - 10 of 1,314 items for :

Clear All
Kevin C J Yuen Departments of Neuroendocrinology and Neurosurgery, Barrow Neurological Institute, University of Arizona College of Medicine and Creighton School of Medicine, Phoenix, Arizona, United States

Search for other papers by Kevin C J Yuen in
Google Scholar
PubMed
Close
,
Gudmundur Johannsson Department of Endocrinology, Sahlgrenska University Hospital and Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Gudmundur Johannsson in
Google Scholar
PubMed
Close
,
Ken K Y Ho The Garvan Institute of Medical Research and the Faculty of Medicine, University of New South Wales, Sydney, Australia

Search for other papers by Ken K Y Ho in
Google Scholar
PubMed
Close
,
Bradley S Miller Pediatric Endocrinology, University of Minnesota Medical School, M Health Fairview Masonic Children’s Hospital, Minneapolis, Minnesota, United States

Search for other papers by Bradley S Miller in
Google Scholar
PubMed
Close
,
Ignacio Bergada Centro de Investigaciones Endocrinológicas "Dr César Bergadá" (CEDIE), CONICET-FEI-División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina

Search for other papers by Ignacio Bergada in
Google Scholar
PubMed
Close
, and
Alan D Rogol Pediatric Diabetes and Endocrinology, University of Virginia, Charlottesville, Virginia, United States

Search for other papers by Alan D Rogol in
Google Scholar
PubMed
Close

but may also be triggered by organic causes. To distinguish between transient and persistent GHD in the adolescent patient transitioning into adulthood requires re-testing in the transition phase after the completion of linear growth ( 1 , 2 , 3

Open access
Sharmin Jahan Department of Medicine, Monash University, Melbourne, Victoria, Australia
Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Victoria, Australia
Department of Endocrinology and Metabolism, BSMMU, Dhaka, Bangladesh

Search for other papers by Sharmin Jahan in
Google Scholar
PubMed
Close
,
Jun Yang Department of Medicine, Monash University, Melbourne, Victoria, Australia
Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Victoria, Australia

Search for other papers by Jun Yang in
Google Scholar
PubMed
Close
,
Jinbo Hu Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Search for other papers by Jinbo Hu in
Google Scholar
PubMed
Close
,
Qifu Li Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Search for other papers by Qifu Li in
Google Scholar
PubMed
Close
, and
Peter J Fuller Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Victoria, Australia

Search for other papers by Peter J Fuller in
Google Scholar
PubMed
Close

factors ( 17 ). It is important to confirm an elevated ARR with additional testing unless the patient has florid biochemical features of PA including suppressed renin, high aldosterone concentration, and hypokalemia. Indeed, a recent meta-analysis of 31

Open access
Dongyan Han Department of Pathology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China

Search for other papers by Dongyan Han in
Google Scholar
PubMed
Close
,
Min Ding Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Min Ding in
Google Scholar
PubMed
Close
,
Rongli Xie Department of General Surgery, RuiJin Hospital Lu Wan Branch, Shanghai Jiaotong University School of Medicine, Shanghai, China

Search for other papers by Rongli Xie in
Google Scholar
PubMed
Close
,
Zhengshi Wang Thyroid Center, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China
Shanghai Center of Thyroid Diseases, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China

Search for other papers by Zhengshi Wang in
Google Scholar
PubMed
Close
,
Guohui Xiao Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Guohui Xiao in
Google Scholar
PubMed
Close
,
Xiaohong Wang Shanghai Rigen Biotechnology Co., Ltd. Shanghai, China

Search for other papers by Xiaohong Wang in
Google Scholar
PubMed
Close
,
Lei Dong Department of Pathology, Shanghai Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Search for other papers by Lei Dong in
Google Scholar
PubMed
Close
,
Zhiqiang Yin Thyroid Center, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China
Shanghai Center of Thyroid Diseases, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China

Search for other papers by Zhiqiang Yin in
Google Scholar
PubMed
Close
, and
Jian Fei Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Research Institute of Pancreatic Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai, China
State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Shanghai Jiao Tong University, Shanghai, China
Institute of Translational Medicine, Shanghai Jiao Tong University, Shanghai, China

Search for other papers by Jian Fei in
Google Scholar
PubMed
Close

current diagnostic modalities routinely used for thyroid disorders in China include palpation, ultrasonography, and serum testing of thyroid function. Ultrasonography based on the American Thyroid Association (ATA) risk stratification criteria is a common

Open access
Grethe Å Ueland Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Medicine, Haukeland University Hospital, Bergen, Norway

Search for other papers by Grethe Å Ueland in
Google Scholar
PubMed
Close
,
Thea Grinde Department of Clinical Science, University of Bergen, Bergen, Norway

Search for other papers by Thea Grinde in
Google Scholar
PubMed
Close
,
Paal Methlie Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Medicine, Haukeland University Hospital, Bergen, Norway
K. G. Jebsen Center for Autoimmune Disorders, University of Bergen, Bergen, Norway

Search for other papers by Paal Methlie in
Google Scholar
PubMed
Close
,
Oskar Kelp Department of Medicine, Akershus University Hospital, Nordbyhagen, Norway

Search for other papers by Oskar Kelp in
Google Scholar
PubMed
Close
,
Kristian Løvås Department of Medicine, Haukeland University Hospital, Bergen, Norway
K. G. Jebsen Center for Autoimmune Disorders, University of Bergen, Bergen, Norway

Search for other papers by Kristian Løvås in
Google Scholar
PubMed
Close
, and
Eystein S Husebye Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Medicine, Haukeland University Hospital, Bergen, Norway
K. G. Jebsen Center for Autoimmune Disorders, University of Bergen, Bergen, Norway

Search for other papers by Eystein S Husebye in
Google Scholar
PubMed
Close

therefore recommended that all patients with AI should be assessed for ACS. The most recent international guidelines recommend the 1 mg overnight dexamethasone suppression test (DST) to screen for ACS ( 1 ). This test is not optimal, as the DST has low

Open access
Laura Potasso Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Basel, Switzerland
Department of Clinical Research, University of Basel, Basel, Switzerland

Search for other papers by Laura Potasso in
Google Scholar
PubMed
Close
,
Julie Refardt Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Basel, Switzerland

Search for other papers by Julie Refardt in
Google Scholar
PubMed
Close
,
Irina Chifu Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Wuerzburg, Wuerzburg Germany

Search for other papers by Irina Chifu in
Google Scholar
PubMed
Close
,
Martin Fassnacht Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Wuerzburg, Wuerzburg Germany
Central Laboratory, University Hospital Wuerzburg, Wuerzburg, Germany

Search for other papers by Martin Fassnacht in
Google Scholar
PubMed
Close
,
Wiebke Kristin Fenske Integrated Research and Treatment Center for Adiposity Diseases, Leipzig University Medical Center, Leipzig, Germany
Leipzig University Medical Center, IFB Adiposity Diseases, Leipzig, Germany

Search for other papers by Wiebke Kristin Fenske in
Google Scholar
PubMed
Close
, and
Mirjam Christ-Crain Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Basel, Switzerland
Department of Clinical Research, University of Basel, Basel, Switzerland

Search for other papers by Mirjam Christ-Crain in
Google Scholar
PubMed
Close

Introduction The hypertonic saline infusion test with continuous infusion of 3% NaCl has recently been put forward as a new test for the diagnosis of diabetes insipidus (DI) ( 1 ). For other indications such as hemorrhagic and septic shock

Open access
Lauren Bell Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
Endocrinology & Diabetes, Salford Royal NHS Foundation Trust, Salford, UK

Search for other papers by Lauren Bell in
Google Scholar
PubMed
Close
,
Ann Louise Hunter Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
Endocrinology & Diabetes, Salford Royal NHS Foundation Trust, Salford, UK

Search for other papers by Ann Louise Hunter in
Google Scholar
PubMed
Close
,
Angelos Kyriacou Endocrinology & Diabetes, Salford Royal NHS Foundation Trust, Salford, UK
CEDM Centre of Endocrinology, Diabetes & Metabolism, Limassol, Cyprus

Search for other papers by Angelos Kyriacou in
Google Scholar
PubMed
Close
,
Annice Mukherjee Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
Endocrinology & Diabetes, Salford Royal NHS Foundation Trust, Salford, UK

Search for other papers by Annice Mukherjee in
Google Scholar
PubMed
Close
, and
Akheel A Syed Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
Endocrinology & Diabetes, Salford Royal NHS Foundation Trust, Salford, UK

Search for other papers by Akheel A Syed in
Google Scholar
PubMed
Close

triiodothyronine (T3) ( 6 ). Additional diagnostic tests can include imaging (commonly ultrasound and radioisotope uptake study) and thyroid autoantibodies, which can help to distinguish GD from other causes of thyrotoxicosis. The autoimmune production of TSH

Open access
Ramjan Sanas Mohamed Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Ramjan Sanas Mohamed in
Google Scholar
PubMed
Close
,
Biyaser Abuelgasim Imperial College School of Medicine, Department of Biochemistry, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Biyaser Abuelgasim in
Google Scholar
PubMed
Close
,
Sally Barker Imperial College School of Medicine, Department of Biochemistry, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Sally Barker in
Google Scholar
PubMed
Close
,
Hemanth Prabhudev Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Hemanth Prabhudev in
Google Scholar
PubMed
Close
,
Niamh M Martin Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK

Search for other papers by Niamh M Martin in
Google Scholar
PubMed
Close
,
Karim Meeran Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK

Search for other papers by Karim Meeran in
Google Scholar
PubMed
Close
,
Emma L Williams Department of Biochemistry, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Emma L Williams in
Google Scholar
PubMed
Close
,
Sarah Darch Department of Biochemistry, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Sarah Darch in
Google Scholar
PubMed
Close
,
Whitlock Matthew Department of Biochemistry, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Whitlock Matthew in
Google Scholar
PubMed
Close
,
Tricia Tan Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK

Search for other papers by Tricia Tan in
Google Scholar
PubMed
Close
, and
Florian Wernig Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Florian Wernig in
Google Scholar
PubMed
Close

Introduction Cushing’s syndrome (CS) is caused by prolonged and inappropriate exposure of tissues to glucocorticoids ( 1 ). Endogenous CS often poses considerable diagnostic challenges. Most guidelines recommend two different tests to screen

Open access
Danielle Christine Maria van der Kaay Erasmus University Medical Center, Department of Pediatrics, Subdivision of Endocrinology, Rotterdam, Netherlands

Search for other papers by Danielle Christine Maria van der Kaay in
Google Scholar
PubMed
Close
,
Anne Rochtus Department of Pediatric Endocrinology, University Hospitals Leuven, Leuven, Belgium

Search for other papers by Anne Rochtus in
Google Scholar
PubMed
Close
,
Gerhard Binder University Children’s Hospital, Pediatric Endocrinology, University of Tübingen, Tübingen, Germany

Search for other papers by Gerhard Binder in
Google Scholar
PubMed
Close
,
Ingo Kurth Institute of Human Genetics, Medical Faculty, RWTH Aachen University, Aachen, Germany

Search for other papers by Ingo Kurth in
Google Scholar
PubMed
Close
,
Dirk Prawitt Center for Paediatrics and Adolescent Medicine, University Medical Center, Mainz, Germany

Search for other papers by Dirk Prawitt in
Google Scholar
PubMed
Close
,
Irène Netchine Sorbonne Université, Centre de Recherche Saint-Antoine, INSERM, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France

Search for other papers by Irène Netchine in
Google Scholar
PubMed
Close
,
Gudmundur Johannsson Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Department of Endocrinology at Sahlgrenska University Hospital, Gothenburg, Sweden

Search for other papers by Gudmundur Johannsson in
Google Scholar
PubMed
Close
,
Anita C S Hokken-Koelega Erasmus University Medical Center, Department of Pediatrics, Subdivision of Endocrinology, Rotterdam, Netherlands

Search for other papers by Anita C S Hokken-Koelega in
Google Scholar
PubMed
Close
,
Miriam Elbracht Institute of Human Genetics, Medical Faculty, RWTH Aachen University, Aachen, Germany

Search for other papers by Miriam Elbracht in
Google Scholar
PubMed
Close
, and
Thomas Eggermann Institute of Human Genetics, Medical Faculty, RWTH Aachen University, Aachen, Germany

Search for other papers by Thomas Eggermann in
Google Scholar
PubMed
Close

for SRS testing) SGA, postnatal growth retardation, short stature, prominent forehead, feeding difficulties, boday asymmetry, café-au-lait spots, Burkitt lymphome at age 9 years. Normal psychomotoric development. (referred for SRS testing

Open access
Bjørn O Åsvold Department of Endocrinology, Department of Public Health, Department of Cancer Research and Molecular Medicine, Department of Medical Biochemistry, St Olavs Hospital, Trondheim University Hospital, P O Box 3250 Sluppen, N-7006 Trondheim, Norway
Department of Endocrinology, Department of Public Health, Department of Cancer Research and Molecular Medicine, Department of Medical Biochemistry, St Olavs Hospital, Trondheim University Hospital, P O Box 3250 Sluppen, N-7006 Trondheim, Norway

Search for other papers by Bjørn O Åsvold in
Google Scholar
PubMed
Close
,
Valdemar Grill Department of Endocrinology, Department of Public Health, Department of Cancer Research and Molecular Medicine, Department of Medical Biochemistry, St Olavs Hospital, Trondheim University Hospital, P O Box 3250 Sluppen, N-7006 Trondheim, Norway
Department of Endocrinology, Department of Public Health, Department of Cancer Research and Molecular Medicine, Department of Medical Biochemistry, St Olavs Hospital, Trondheim University Hospital, P O Box 3250 Sluppen, N-7006 Trondheim, Norway

Search for other papers by Valdemar Grill in
Google Scholar
PubMed
Close
,
Ketil Thorstensen Department of Endocrinology, Department of Public Health, Department of Cancer Research and Molecular Medicine, Department of Medical Biochemistry, St Olavs Hospital, Trondheim University Hospital, P O Box 3250 Sluppen, N-7006 Trondheim, Norway

Search for other papers by Ketil Thorstensen in
Google Scholar
PubMed
Close
, and
Marit R Bjørgaas Department of Endocrinology, Department of Public Health, Department of Cancer Research and Molecular Medicine, Department of Medical Biochemistry, St Olavs Hospital, Trondheim University Hospital, P O Box 3250 Sluppen, N-7006 Trondheim, Norway
Department of Endocrinology, Department of Public Health, Department of Cancer Research and Molecular Medicine, Department of Medical Biochemistry, St Olavs Hospital, Trondheim University Hospital, P O Box 3250 Sluppen, N-7006 Trondheim, Norway

Search for other papers by Marit R Bjørgaas in
Google Scholar
PubMed
Close

Introduction The 1 mg overnight dexamethasone suppression test (DST) is a common initial test for endogenous Cushing's syndrome (1) . The principle of the test is that dexamethasone will suppress ACTH and cortisol secretion in healthy individuals

Open access
Jose M Garcia GRECC VA Puget Sound HCS/University of Washington, Seattle, Washington, USA

Search for other papers by Jose M Garcia in
Google Scholar
PubMed
Close
,
Beverly M K Biller Massachusetts General Hospital, Neuroendocrine Unit, Boston, Massachusetts, USA

Search for other papers by Beverly M K Biller in
Google Scholar
PubMed
Close
,
Márta Korbonits Barts and the London School of Medicine, Queen Mary University of London, Endocrinology, London, UK

Search for other papers by Márta Korbonits in
Google Scholar
PubMed
Close
,
Vera Popovic University of Belgrade, Medical Faculty, Belgrade, Serbia

Search for other papers by Vera Popovic in
Google Scholar
PubMed
Close
,
Anton Luger Division of Endocrinology and Metabolism, Medical University, General Hospital, Vienna, Austria

Search for other papers by Anton Luger in
Google Scholar
PubMed
Close
,
Christian J Strasburger Charité-Universitätsmedizin, Clinical Endocrinology CCM, Berlin, Germany

Search for other papers by Christian J Strasburger in
Google Scholar
PubMed
Close
,
Philippe Chanson Assistance Publique-Hôpitaux de Paris, Hôpital de Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, and Université Paris-Saclay, Univ. Paris-Sud, Inserm, Signalisation Hormonale, Physiopathologie Endocrinienne et Métabolique, Le Kremlin-Bicêtre, France

Search for other papers by Philippe Chanson in
Google Scholar
PubMed
Close
,
Ronald Swerdloff The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California, USA

Search for other papers by Ronald Swerdloff in
Google Scholar
PubMed
Close
,
Christina Wang The Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California, USA

Search for other papers by Christina Wang in
Google Scholar
PubMed
Close
,
Rosa Rosanna Fleming Strongbridge Biopharma, Trevose, Pennsylvania, USA

Search for other papers by Rosa Rosanna Fleming in
Google Scholar
PubMed
Close
,
Fredric Cohen Strongbridge Biopharma, Trevose, Pennsylvania, USA

Search for other papers by Fredric Cohen in
Google Scholar
PubMed
Close
,
Nicola Ammer Aeterna Zentaris GmbH, Frankfurt, Hessen, Germany

Search for other papers by Nicola Ammer in
Google Scholar
PubMed
Close
,
Gilbert Mueller Aeterna Zentaris GmbH, Frankfurt, Hessen, Germany

Search for other papers by Gilbert Mueller in
Google Scholar
PubMed
Close
,
Nicky Kelepouris Novo Nordisk Inc., Plainsboro, New Jersey, USA

Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed
Close
,
Frank Strobl Novo Nordisk Inc., Plainsboro, New Jersey, USA

Search for other papers by Frank Strobl in
Google Scholar
PubMed
Close
,
Vlady Ostrow Novo Nordisk Inc., Plainsboro, New Jersey, USA

Search for other papers by Vlady Ostrow in
Google Scholar
PubMed
Close
, and
Kevin C J Yuen University of Arizona College of Medicine and Creighton School of Medicine, Barrow Pituitary Center, Barrow Neurological Institute, Phoenix, Arizona, USA

Search for other papers by Kevin C J Yuen in
Google Scholar
PubMed
Close

on diagnosis and disease progression ( 17 ). Thus, except in patients with panhypopituitarism and low insulin-like growth factor I (IGF-I) levels, the diagnosis of AGHD often requires confirmation using a provocative GH stimulation test (GHST) ( 18

Open access